Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.KASL clinical practice guidelines: management of chronic hepatitis BBiomarker-Based Approaches for Assessing Alcohol Use DisordersManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsRevised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersCurrent role of transient elastography in the management of chronic hepatitis B patientsFactors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisRisk prediction models for hepatocellular carcinoma in different populations.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.Heritability of liver enzyme levels estimated from genome-wide SNP data.Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 dataDevelopment of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).Phosphorylation of Histone H2A.X in Peripheral Blood Mononuclear Cells May Be a Useful Marker for Monitoring Cardiometabolic Risk in Nondiabetic Individuals.Serum Alanine Aminotransferase Levels within Normal Range Have Different Associations with Augmentation Index and Other Cardiometabolic Risk Factors in Nondrinkers and Drinkers: A Chinese Community-Based AnalysisChronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in MenPrediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts.SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver diseasePrevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus.Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelinesCirculating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.Natural history of chronic hepatitis B: phases in a complex relationship.Impacts of common factors of life style on serum liver enzymes.Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Current status of antiviral therapy for hepatitis BUpper limits of normal for serum alanine aminotransferase levels in Chinese Han population.Characteristics of chronic hepatitis B patients who underwent liver biopsies.Ethnicity and the diagnosis gap in liver disease: a population-based study.The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI).Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trialIndependent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levelsClinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus InfectionProtein kinase expression as a predictive factor for interferon response in chronic hepatitis C patientsFactors associated with significant liver fibrosis assessed using transient elastography in general population.New approaches in the management of chronic hepatitis B: role of tenofovir.
P2860
Q26740195-4DEBCA15-2DFD-4E77-854F-348C81232C05Q26752475-65A7796F-B60C-44E0-9EAA-CA083E1E1BE4Q26772931-1E8CFD72-B2CE-4B18-9943-F50C76E8E3F0Q27008984-33CADCAA-CE9F-4007-874F-5D25FA6BDB00Q28386713-24EBABBE-D1E5-4824-A4EA-570F1973F50BQ30358894-F1FB3502-37EB-442C-AA7F-A5D30C368B19Q30374334-99CAF3B4-EAA4-4D22-BD29-10371C155F2FQ30383460-15FD93FC-108C-497A-821A-89BB0231CAACQ30391932-F97E12A1-1FD7-4F4B-9015-FDABFFD25BABQ30570152-5DB7680B-1F8F-4881-B1A7-07BAF07B8215Q30871999-6E805345-09AA-4E75-909B-F592271CAE7AQ31110102-5C173AA2-6E90-474D-ADD0-4D058AB47BCCQ33282214-9851B6A8-3CA4-4B3E-AC02-842817933661Q33717556-60145052-842F-4A20-9B95-0239EDC94611Q33717563-E791F458-FC33-4C97-8C61-D7BDA2887E86Q33718958-BF3FD17D-2382-4BDE-99C2-7213B24F5FD8Q33734975-70EC0515-FB8C-4747-9824-8D5A27055924Q33744789-514EFB3E-20BD-483E-863C-749156BE2686Q33759095-B371E8A6-B309-4C09-A5E4-71B0EC592EA8Q33772096-3692BF8C-91F6-438E-8770-6360069D4237Q33836312-367ED373-522C-4216-9E3B-6FCACCEAC123Q33855708-A4C9651F-E7B0-4769-A174-ED78F6EC1AD6Q33924942-2A1546FE-160B-4FF3-B878-412AE4621AA8Q34036650-6EEC9F71-5680-40B6-840A-97AA946D5699Q34137334-D70DF124-C886-42D4-A33D-91D41F1F8EB9Q34168465-BE224FDB-E506-49F0-9AC7-3A7A762FB328Q34408879-E683C528-1BCD-4DD8-A524-208FB09D786AQ34409744-7FA52D57-171E-4BF7-BF75-65EF1884113FQ34414362-82723691-E361-4215-9DF6-220D793BCD7AQ34452602-8F5E3CFB-2CA9-47D1-9CB8-F393FDA61F5EQ34525079-5A888880-BFAB-458A-8688-D6A3F9A585D4Q34574104-455247DB-1381-4883-BA64-E3AFC7A2D1E7Q34577683-50E0EAC1-1A50-4156-84D4-BF6DAC9B21F3Q34672380-3EAFEE11-D2EB-4F24-963C-FD3ADFC34CB7Q34718164-3DD82F4E-0BDC-46A6-82FD-6845C25DC5B8Q34758973-5B87708D-E4C2-429F-B1AF-4C757E048BF3Q34892826-13B37CAE-00AD-44A2-B0FA-4DC3851D5565Q34961241-825997EE-6622-46CB-B73C-5A489A33C878Q35012048-C22AC0F8-6A36-4DD0-ACA9-681B599631CDQ35026531-A2C9AA83-6983-46D0-9172-83ED8CDAAAA7
P2860
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Normal serum aminotransferase ...... ases: prospective cohort study
@ast
Normal serum aminotransferase ...... ases: prospective cohort study
@en
type
label
Normal serum aminotransferase ...... ases: prospective cohort study
@ast
Normal serum aminotransferase ...... ases: prospective cohort study
@en
prefLabel
Normal serum aminotransferase ...... ases: prospective cohort study
@ast
Normal serum aminotransferase ...... ases: prospective cohort study
@en
P2860
P50
P1433
P1476
Normal serum aminotransferase ...... ases: prospective cohort study
@en
P2093
Dae Kyu Oh
Kwang Hyub Han
P2860
P356
10.1136/BMJ.38050.593634.63
P407
P577
2004-03-17T00:00:00Z